Seeking an experienced Site Manager - Clinical Trials to lead and oversee end-to- end clinical trial execution and site administration. The ideal candidate will be responsible for ensuring regulatory compliance, operational excellence, staff management, sponsor/CRO coordination, and smooth day-to-day site functioning across multiple studies.
PhD in any field of Life Sciences. Prior experience in mammalian cell culture, RNA-Seq, immunology, animal handling, IF/IHC of tissue will be preferred
First Class Post Graduate Degree (including Integrated PG Degrees) in Biophysics/ Biochemistry/Biotechnology or any other branch of Life/Biological/Physical Science OR Second Class Post Graduate Degree in Biological/Life/Physical Sciences with Ph.D.
Doctoral degree in Molecular Biology / Biochemistry / Plant Science / Life Sciences / Biotechnology / Bioinformatics or equivalent from a recognized university or equivalent.
Master degree or equivalent in Science, Engineering or Technology with at least 60% marks or equivalent. The candidates with at least one of the national level competitive exams qualifications such as NET/GATE/GPAT etc will be given preference.
Development of new extraction kits on various extraction platforms. Upgradation of existing products in view of attributes such as, but not limiting to performance improvement, cost reduction, new feature.
To have knowledge of ICH guidelines and other regional regulatory requirements including USFDA, EMA, NMPA, TGA, CADIFA and other global regulatory market.
The regulatory submissions to the FDA and EMA are supported by previously announced results from the Viti-Up studies evaluating the safety and efficacy of upadacitinib in patients with NSV.
Alembic Pharmaceuticals Limited has strengthened its US generics portfolio with the final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) covering Carbidopa, Levodopa and Entacapone Tablets.
Zydus Lifesciences has achieved a significant regulatory milestone as the U.S. Food and Drug Administration (USFDA) granted Orphan Drug Designation (ODD) to its novel molecule Desidustat for the treatment of Sickle Cell Disease (SCD). The designation highlights the growing recognition of the urgent need for new and effective therapies in this rare and challenging condition.
B.Pharmacy with experience or M.Pharma, Master Degree in Chemistry / Microbiology. Candidates having experience in testing of drugs will be given preference. The candidates should also have sound knowledge of computer operation.
PhD with a post-doctoral experience of 0-2 years. Applicants should have a PhD in Human Genetics, Genomics, Forensic Science, Molecular Biology, Bioinformatics, or a related discipline in Life Sciences.
Completed applications are invited from eligible persons to fill the Pharmacist in Government Medical College Hospital, Government Hospital and Primary Health Centers through Kallakurichi District Health Association
PhD with a post-doctoral experience of 0-2 years. Applicants should have a PhD in Human Genetics, Genomics, Molecular Biology or a related discipline in Life Sciences.
The candidate should have a first-class post-graduate degree in Biochemistry / Biotechnology / Molecular and Human Genetics /Zoology / Animal Science / Life Sciences with qualified NET / GATE or equivalent examination.
ECHS invites applications to engage following Medical, Para Medical and Non Medical staff on contractual basis in ECHS Polyclinic Bhopal for a period of one year renewable for additional period of one year, till attaining the maximum age subject to performance.